A critical breakthrough in cancer research is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial malignant protector protein is frequently inactivated in several kinds of tumors, https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research